Who Should You Sell Your Dental Practice To?

Quick Answer

You should sell your dental practice to a properly funded, professionally compliant buyer whose offer fits your financial goals and whose operating values protect patients, staff and your professional legacy. The right buyer is not automatically the one offering the highest headline price.

For many owners, a sale is the largest business transaction of their career. It may also determine what happens to a team built over decades, how patients experience the transition and whether the owner can continue practising with confidence. Choosing the buyer therefore requires both financial and human due diligence.

What does the “right buyer” mean for a dental practice?

The right buyer is the buyer most likely to deliver the outcome you actually want. That outcome may include:

1. A high level of cash at completion.
2. A dependable future income from clinical work.
3. Less administration and ownership responsibility.
4. Continued employment for staff.
5. Protection of patient care and local reputation.
6. A gradual rather than abrupt exit.
7. A future opportunity for partners or associates.
8. Retaining and leasing the property.

These goals can conflict. A buyer offering the highest price may require a demanding earnout and tight performance targets. A buyer promising maximum autonomy may offer less operational support. A family successor may protect culture but struggle to fund the transaction. The owner should rank priorities before comparing buyers.

Should you sell to another individual dentist?

An individual dentist can be the right buyer when personal continuity and local ownership matter most. The buyer may take over the existing practice, remain visible to patients and preserve the practice’s identity.

This route is attractive when the practice is within the individual’s funding capacity and when the buyer has enough management ability to take over. It may also allow a more personal handover.

The owner should test more than clinical competence. Ask whether the buyer can manage cash flow, staff, compliance, billing, marketing, equipment and debt. Confirm funding early. A transaction that depends on uncertain finance can fail late, after months of disclosure and disruption.

Should you sell to an associate or existing partner?

An associate or partner can be an excellent buyer because the relationship has already been tested. Patients and staff may know the successor, and the new owner understands the practice’s strengths and frustrations.

The risk is that familiarity encourages vague agreements. A staged buy in needs clear valuation rules, decision rights, funding dates, profit distribution, deadlock mechanisms and a path to full ownership. The seller should not remain responsible for liabilities while losing practical control.

An internal sale should still use independent advisers. The parties may have a good relationship today, but the documents must also work if circumstances change.

Should you sell to a dental group or DSO?

A dental group or DSO can be the right buyer when the owner wants stronger transaction capacity, shared services and a defined post sale role. A group may have access to capital, finance, operations, marketing, recruitment and reporting resources that an individual buyer cannot easily reproduce.

The term DSO is not enough to establish fit. Some DSOs provide services without buying practices. Some acquire businesses and centralise many decisions. Others combine local clinical leadership with central business support.

Ask the group:

1. What exactly are you buying?
2. How are professional and non clinical activities structured?
3. Which decisions remain with clinicians?
4. What changes will happen in the first 100 days?
5. Will the practice keep its name?
6. How are staff evaluated and supported?
7. What are the seller’s targets after completion?
8. How will the deal be funded?

Mia Healthcare offers standalone practice services, service to acquire and direct acquisition. It describes itself as family owned and clinician led, with sell and stay clinically as a preferred structure. These claims provide a starting point for due diligence, not a substitute for reviewing the specific offer and agreements.

How important is buyer funding?

Funding is essential because an attractive offer has little value if the buyer cannot complete it. Ask for a clear explanation of the funding source, approval status, conditions and expected completion date.

The purchase price may include:

1. Cash at completion.
2. Deferred fixed payments.
3. An earnout linked to future performance.
4. Seller finance.
5. Equity or another continuing interest.

Each component carries different risk. Cash at completion is generally more certain than a payment depending on future revenue, profit or the owner remaining at work. Deferred payments should be supported by clear security, default and reporting provisions where appropriate.

Mia names Vumela Fund, Anza Capital, Bidvest and FNB among the institutions supporting its ecosystem. In any specific transaction, the seller should still confirm what funding is committed and which conditions remain.

How should you compare the purchase price?

Compare economic value, not only the large number on page one. A useful comparison considers:

1. Cash paid at completion.
2. Probability and timing of deferred payments.
3. Earnout definitions and control over the result.
4. Debt, working capital and other price adjustments.
5. Tax consequences of the structure.
6. Professional income after the sale.
7. Costs of warranties, indemnities or retained liabilities.
8. Obligations to work, refer, remain available or achieve targets.

For example, an offer of R10 million with half dependent on three years of growth may be less attractive than an offer of R8 million mostly payable at completion. This is only an illustration. The correct comparison depends on the probability, timing and tax treatment of each payment.

How important is cultural and ethical fit?

Cultural fit matters because the buyer becomes the custodian of relationships that created the practice’s value. A mismatch can damage staff retention, patient trust and the seller’s willingness to remain.

Test culture through evidence:

1. Speak to practice owners who have already joined the group.
2. Meet the people who will actually operate the practice.
3. Ask how the buyer handled a difficult integration or underperforming period.
4. Review how clinical complaints, staffing disputes and patient feedback are managed.
5. Observe whether the buyer answers direct questions clearly.
6. Discuss scenarios where commercial targets and clinical judgement may conflict.

Values stated in marketing are useful, but the operating model and contracts reveal how decisions will really be made.

How should the buyer protect clinical independence?

The buyer should be able to explain how registered practitioners retain responsibility for diagnosis, treatment planning, consent, record keeping and professional standards. Commercial systems may support the practice, but they should not improperly override clinical judgement.

The transaction and ongoing service agreements must comply with current HPCSA rules on business structures, corporate involvement, fee arrangements, conflicts and professional independence. If the answer is unclear, obtain specialist advice before progressing.

What should happen to staff?

A good buyer treats the team as part of the practice’s continuity, not merely a cost line. Ask for the buyer’s plan for roles, remuneration, benefits, reporting lines, training and possible redundancies.

Where a business transfers as a going concern, section 197 of the Labour Relations Act may apply. The legal effect depends on the transaction. Owners should obtain labour advice before discussing outcomes with staff or changing contracts.

Do not promise that every role will remain unchanged unless the buyer has made a binding commitment. At the same time, unnecessary secrecy can damage trust. Plan the communication sequence carefully with advisers.

What should happen to patients and records?

The transition should protect continuity of care, confidentiality, consent and lawful handling of personal information. The parties should agree who becomes responsible for record custody, how patients will be informed, what happens to ongoing treatment and how complaints or historic claims are handled.

Early due diligence should use aggregated or anonymised information where possible. Patient level access should be controlled and justified. The purchase agreement, professional handover plan and POPIA measures should align.

Should the buyer keep the practice brand?

There is no single correct answer. A trusted local brand may have significant value, while a group brand may bring marketing strength and a broader patient promise.

Ask whether the existing name will be retained, endorsed or replaced, and over what period. If the practice bears the seller’s personal name, agree how long it can be used, in what context and what happens after the seller leaves.

How should your continuing role affect buyer choice?

If you want to keep practising, choose a buyer you can work with after the sale. The clinical agreement should address:

1. Working days and locations.
2. Remuneration and calculation method.
3. Laboratory, material and support costs.
4. Leave, illness and professional development.
5. Clinical autonomy and governance.
6. Targets and how they relate to any earnout.
7. Professional indemnity and historic claims.
8. Restraint and non solicitation provisions.
9. How either party can end the relationship.
10. What happens to deferred purchase payments if the working relationship ends.

A buyer who offers an excellent sale price but an unworkable clinical future may not be the right buyer.

What warning signs should make you pause?

Pause if a buyer:

1. Pressures you to sign broad exclusivity before explaining the process.
2. Avoids showing evidence of funding.
3. Uses a valuation multiple without examining maintainable earnings and risk.
4. Requests identifiable patient data too early.
5. Cannot explain the professional ownership and billing structure.
6. Promises that tax, employment or HPCSA issues are “standard” without specialist review.
7. Makes most of the price conditional but leaves the measurement vague.
8. Refuses reasonable reference conversations.
9. Expects control before paying or completing.
10. Treats your future clinical role as an afterthought.

How can a service relationship help test the buyer?

A service relationship can show how a potential buyer communicates, handles data, supports staff and responds when results are difficult. It can also improve financial reporting and reduce surprises before valuation.

This is the logic behind Mia’s service to acquire model. An owner can take selected services while both sides assess fit. The services do not guarantee a sale, and the engagement letter should preserve clear termination rights and define whether information can be used for acquisition discussions.

The advantage is practical evidence. The risk is that a close working relationship may reduce the owner’s willingness to test other options. Independent advice remains valuable.

What is the best way to make the final decision?

Create a weighted buyer scorecard before receiving final offers. Score financial certainty, total value, regulatory clarity, clinical governance, staff plan, patient continuity, property terms, future role, culture and references. Then review the scorecard with independent legal, tax and accounting advisers.

To explore Mia as a potential practice partner or buyer, visit www.mia-healthcare.com or WhatsApp Dr Zane Stenning on +27 65 536 1760.

Important note: This article is general information and does not constitute legal, tax, valuation, accounting, employment or financial advice. The appropriate buyer and structure depend on the practice, owner’s goals and current South African rules.